Systems glycobiology for glycoengineering

Current Opinion in Biotechnology

Volumn 30, Issue , 2014, Pages 218-224

  Spahn, Philipp N ^a   Lewis, Nathan E ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOBIOLOGY;

GLYCAN; GLYCOSYLTRANSFERASE; MESSENGER RNA; RECOMBINANT PROTEIN;

BINDING KINETICS; BIOENGINEERING; CALIBRATION; CARBOHYDRATE TRANSPORT; CELL ENGINEERING; CELL LINE; CHEMICAL REACTION KINETICS; COMPUTER MODEL; DNA MODIFICATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME LOCALIZATION; GLYCOBIOLOGY; GLYCOENGINEERING; GLYCOSYLATION; GOLGI COMPLEX; PROTEIN FOLDING; PROTEOGLYCAN SYNTHESIS; REVIEW; RNA TRANSPORT; HUMAN; METABOLIC ENGINEERING; METABOLISM; PHARMACEUTICS;

BIOPHARMACEUTICS; GLYCOSYLATION; HUMANS; METABOLIC ENGINEERING; RECOMBINANT PROTEINS;

EID: 84907274931     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2014.08.004     Document Type: Review

References (47)

1. Moremen K.W., Tiemeyer M., Nairn A.V. Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol 2012, 13:448-462.
2. Feige M.J., Nath S., Catharino S.R., Weinfurtner D., Steinbacher S., Buchner J. Structure of the murine unglycosylated IgG1 Fc fragment. J Mol Biol 2009, 391:599-608.
3. Sumer-Bayraktar Z., Kolarich D., Campbell M.P., Ali S., Packer N.H., Thaysen-Andersen M. N-glycans modulate the function of human corticosteroid-binding globulin. Mol Cell Proteomics 2011, 10. M111.009100.
4. Griebenow K.A.I., Sola R.J. Effects of glycosylation on the stability of protein pharmaceuticals. J Pharm Sci 2009, 98:1223-1245.
5. Freire-de-Lima L. Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition. Front Oncol 2014, 4:59.
6. Freeze H.H., Chong J.X., Bamshad M.J., Ng B.G. Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am J Hum Genet 2014, 94:161-175.
7. Jefferis R. Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 2009, 8:226-234.
8. Hossler P. Protein glycosylation control in mammalian cell culture: past precedents and contemporary prospects. Genomics and Systems Biology of Mammalian Cell Culture 2012, 187-219.
9. Del Val I.J., Kontoravdi C., Nagy J.M. Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns. Biotechnol Prog 2010, 26:1505-1527.
10. St Amand M.M., Radhakrishnan D., Robinson A.S., Ogunnaike B.A. Identification of manipulated variables for a glycosylation control strategy. Biotechnol Bioeng 2014, 111:1957-1970.
11. Xu X., Nagarajan H., Lewis N.E., Pan S., Cai Z., Liu X., Chen W., Xie M., Wang W., Hammond S., et al. The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol 2011, 29:735-741.
12. Lewis N.E., Liu X., Li Y., Nagarajan H., Yerganian G., O'Brien E., Bordbar A., Roth A.M., Rosenbloom J., Bian C., et al. Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome. Nat Biotechnol 2013, 31:759-765.
13. Thaysen-Andersen M., Packer N.H. Site-specific glycoproteomics confirms that protein structure dictates formation of N-glycan type, core fucosylation and branching. Glycobiology 2012, 22:1440-1452.
14. Yu L.X. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res 2008, 25:781-791.
15. Rakus J.F., Mahal L.K. New technologies for glycomic analysis: toward a systematic understanding of the glycome. Annu Rev Anal Chem 2011, 4:367-392.
16. Tang H., Mayampurath A., Yu C.-Y., Mechref Y. Bioinformatics protocols in glycomics and glycoproteomics. Curr Protoc Protein Sci 2014, 76. 2.15.1-7.
17. Neelamegham S., Liu G. Systems glycobiology: biochemical reaction networks regulating glycan structure and function. Glycobiology 2011, 21:1541-1553.
18. Shelikoff M., Sinskey a J., Stephanopoulos G. A modeling framework for the study of protein glycosylation. Biotechnol Bioeng 1996, 50:73-90.
19. Senger R.S., Karim M.N. Variable site-occupancy classification of N-linked glycosylation using artificial neural networks. Biotechnol Prog 2005, 21:1653-1662.
20. Zielinska D.F., Gnad F., Wiśniewski J.R., Mann M. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell 2010, 141:897-907.
21. Umana P., Bailey J.E. A mathematical model of N-linked glycoform biosynthesis. Biotechnol Bioeng 1997, 55:890-908.
22. Harazono A., Kawasaki N., Kawanishi T., Hayakawa T. Site-specific glycosylation analysis of human apolipoprotein B100 using LC/ESI MS/MS. Glycobiology 2005, 15:447-462.
23. Harazono A., Kawasaki N., Itoh S., Hashii N., Ishii-Watabe A., Kawanishi T., Hayakawa T. Site-specific N-glycosylation analysis of human plasma ceruloplasmin using liquid chromatography with electrospray ionization tandem mass spectrometry. Anal Biochem 2006, 348:259-268.
24. An Y., Cipollo J.F. An unbiased approach for analysis of protein glycosylation and application to influenza vaccine hemagglutinin. Anal Biochem 2011, 415:67-80.
25. Krambeck F.J., Betenbaugh M.J. A mathematical model of N-linked glycosylation. Biotechnol Bioeng 2005, 92:711-728.
26. Krambeck F.J., Bennun S.V., Narang S., Choi S., Yarema K.J., Betenbaugh M.J. A mathematical model to derive N-glycan structures and cellular enzyme activities from mass spectrometric data. Glycobiology 2009, 19:1163-1175.
27. Bennun S.V., Yarema K.J., Betenbaugh M.J., Krambeck F.J. Integration of the transcriptome and glycome for identification of glycan cell signatures. PLOS Comput Biol 2013, 9:e1002813.
28. Kawano S., Hashimoto K., Miyama T., Goto S., Kanehisa M. Prediction of glycan structures from gene expression data based on glycosyltransferase reactions. Bioinformatics 2005, 21:3976-3982.
29. Suga A., Yamanishi Y., Hashimoto K., Goto S., Kanehisa M. An improved scoring scheme for predicting glycan structures from gene expression data. Genome Inform 2007, 18:237-246.
30. Liu G., Marathe D.D., Matta K.L., Neelamegham S. Systems-level modeling of cellular glycosylation reaction networks: O-linked glycan formation on natural selectin ligands. Bioinformatics 2008, 24:2740-2747.
31. Meuris L., Santens F., Elson G., Festjens N., Boone M., Dos Santos A., Devos S., Rousseau F., Plets E., Houthuys E., et al. GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins. Nat Biotechnol 2014, 32:485-489.
32. Yamane-Ohnuki N., Kinoshita S., Inoue-Urakubo M., Kusunoki M., Iida S., Nakano R., Wakitani M., Niwa R., Sakurada M., Uchida K., et al. Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnol Bioeng 2004, 87:614-622.
33. Hossler P., Mulukutla B.C., Hu W.-S. Systems analysis of N-glycan processing in mammalian cells. PLoS ONE 2007, 2:e713.
34. Martínez-Menárguez J.A. Intra-golgi transport: roles for vesicles, tubules, and cisternae. ISRN Cell Biol 2013, 1-15.
35. Del Val I.J., Nagy J.M., Kontoravdi C. A dynamic mathematical model for monoclonal antibody N-linked glycosylation and nucleotide sugar donor transport within a maturing Golgi apparatus. Biotechnol Prog 2011, 27:1730-1743.
36. Jedrzejewski P.M., del Val I.J., Constantinou A., Dell A., Haslam S.M., Polizzi K.M., Kontoravdi C. Towards controlling the glycoform: a model framework linking extracellular metabolites to antibody glycosylation. Int J Mol Sci 2014, 15:4492-4522.
37. Kaveh O., Hengameh A., Johannes G., Legge M.M., Jeno S., Hector B. Novel dynamic model to predict the glycosylation pattern of monoclonal antibodies from extracellular cell culture conditions. 12th Symposium on Computer Applications in Biotechnology 2013.
38. Agrawal P., Kurcon T., Pilobello K.T., Rakus J.F., Koppolu S., Liu Z., Batista B.S., Eng W.S., Hsu K.-L., Liang Y., et al. Mapping posttranscriptional regulation of the human glycome uncovers microRNA defining the glycocode. Proc Natl Acad Sci U S A 2014, 111:4338-4343.
39. Wu M., Chan C. Prediction of therapeutic microRNA based on the human metabolic network. Bioinformatics 2014, 30:1163-1171.
40. Senger R.S., Karim M.N. Prediction of N-linked glycan branching patterns using artificial neural networks. Math Biosci 2008, 211:89-104.
41. Schwede T. Protein modeling: what happened to the “protein structure gap“?. Structure 2013, 21:1531-1540.
42. Kim P.-J., Lee D.-Y., Jeong H. Centralized modularity of N-linked glycosylation pathways in mammalian cells. PLoS ONE 2009, 4:e7317.
43. Lewis N.E., Nagarajan H., Palsson B.O. Constraining the metabolic genotype-phenotype relationship using a phylogeny of in silico methods. Nat Rev Microbiol 2012, 10:291-305.
44. Lakshmanan M., Koh G., Chung B.K.S., Lee D.-Y. Software applications for flux balance analysis. Brief Bioinform 2014, 15:108-122.
45. Murrell M.P., Yarema K.J., Levchenko A. The systems biology of glycosylation. ChemBioChem 2004, 5:1334-1347.
46. Shental-Bechor D., Levy Y. Folding of glycoproteins: toward understanding the biophysics of the glycosylation code. Curr Opin Struct Biol 2009, 19:524-533.
47. Kildegaard H.F., Baycin-Hizal D., Lewis N.E., Betenbaugh M.J. The emerging CHO systems biology era: harnessing the 'omics revolution for biotechnology. Curr Opin Biotechnol 2013, 24:1102-1107.